Antiplatelet Therapy in Patients With Anticoagulants Undergoing Percutaneous Coronary Stenting (from STENTIng and oral antiCOagulants [STENTICO])

American Journal of Cardiology

Volumn 104, Issue 3, 2009, Pages 338-342

  Gilard, Martine ^a   Blanchard, Didier ^b   Helft, Gérard ^c   Carrier, Didier ^d   Eltchaninoff, Helene ^e   Belle, Loic ^f   Finet, Gérard ^h   Le Breton, Hervé ^g   Boschat, Jacques ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Clinique Saint Gatien   (France)

^c University of Paris   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f Hospital of Annecy   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; WARFARIN;

ACUTE CORONARY SYNDROME; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY STENT; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEMATOMA; HEMATURIA; HUMAN; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SHEATH RELATED HEMATOMA; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; STENT THROMBOSIS; STROKE; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ARTERY DISEASE; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67651099151     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.03.053     Document Type: Article

References (22)

1. Leon M.B., Baim D.S., Popma J.J., Gordon P.C., Cutlip D.E., Ho K.K., Giambartolomei A., Diver D.J., Lasorda D.M., Williams D.O., Pocock S.J., and Kuntz R.E. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 339 (1998) 1665-1671
2. Bertrand M.E., Legrand V., Boland J., Fleck E., Bonnier J., Emmanuelson H., Vrolix M., Missault L., Chierchia S., Casaccia M., Niccoli L., Oto A., White C., Webb-Peploe M., Van Belle E., and McFadden E.P. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation 98 (1998) 1597-1603
3. Taniuchi M., Kurz H.I., and Lasala J.M. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 104 (2001) 539-543
4. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
5. Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., Jorgensen E., Marco J., Nordrehaug J.E., Ruzyllo W., Urban P., Stone G.W., and Wijns W. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
6. Schömig A., Neumann F.J., Kastrati A., Schühlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E.M., Richardt G., Alt E., Schmitt C., and Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334 (1996) 1084-1089
7. Gage B.F., Gage B.F., van Walraven C., Pearce L., Hart R.G., Koudstaal P.J., Boode B.S., and Petersen P. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110 (2004) 2287-2292
8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
9. Rubboli A., Colletta M., Herzfeld J., Sangiorgio P., and Di Pasquale G. Peri-procedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention. Coron Artery Dis 18 (2007) 193-199
10. Porter A., Konstantino Y., Iakobishvili Z., Shachar L., Battler A., and Hasdai D. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 68 (2006) 56-61
11. Lip G.Y.H., and Karpha M. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest 130 (2006) 1823-1827
12. Orford J.L., Fasseas P., Melby S., Burger K., Steinhubl S.R., Holmes D.R., and Berger P.B. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 147 (2004) 463-467
13. Mattichak S.J., Reed P.S., Gallagher M.J., Boura J.A., O'Neill W.W., and Kahn J.K. Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol 18 (2005) 163-166
14. Khurram Z., Chou E., Minutello R., Bergman G., Parikh M., Naidu S., Wong S.C., and Hong M.K. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 18 (2006) 162-164
15. Nguyen M.C., Lim Y.L., Walton A., Lefkovits J., Agnelli G., Goodman S.G., Budaj A., Gulba D.C., Allegrone J., Brieger D., and GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?. Eur Heart J 28 (2007) 1717-1722
16. Rubboli A., Colletta M., Sangiorgio P., and Di Pasquale G. Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice. Ital Heart J 5 (2004) 851-856
17. Agostoni P., Biondi-Zoccai G.G., de Benedictis M.L., Rigattieri S., Turri M., Anselmi M., Vassanelli C., Zardini P., Louvard Y., and Hamon M. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 44 (2004) 349-356
18. Madan P., Elayda M.A., Lee V.V., and Wilson J.M. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score. Am Heart J 155 (2008) 1068-1074
19. Segal A.Z., Abernethy W.B., Palacios I.F., BeLue R., and Rordorf G. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology 56 (2001) 975-977
20. Fuchs S., Stabile E., Kinnaird T.D., Mintz G.S., Gruberg L., Canos D.A., Pinnow E.E., Kornowski R., Suddath W.O., Satler L.F., Pichard A.D., Kent K.M., and Weissman N.J. Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation 106 (2002) 86-91
21. Leker R.R., Pollak A., Abramsky O., and Ben-Hur T. Abundance of left hemispheric embolic strokes complicating coronary angioplasty and PTCA. J Neurol Neurosurg Psychiatry 66 (1999) 116-117
22. Dukkipati S., O'Neill W.W., Harjai K.J., Sanders W.P., Deo D., Boura J.A., Bartholomew B.A., Yerkey M.W., Sadeghi H.M., and Kahn J.K. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol 43 (2004) 1161-1167